ArticleMedical science monitor : international medical journal of experimental and clinical research2025
Glucagon-Like Peptide-1 Receptor Agonists Lead to Gastrointestinal Benefits in Patients with Type 2 Diabetes: A Real-World Study.
Jung-Hui Hsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.